AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer: GELATO-trial
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2017
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms GELATO-trial
- 31 Aug 2018 Biomarkers information updated
- 15 Nov 2017 Status changed from not yet recruiting to recruiting.
- 13 Sep 2017 Planned initiation date changed from 1 Jul 2017 to 1 Oct 2017.